- Received U.S. Food and Drug Administration ("FDA") Breakthrough Therapy Designation ("BTD") for CYB003, its proprietary deuterated psilocybin analog in...
results
Q1 total revenue growth of 18%, year-over-year Subscription services ARR over $1.4 billion SANTA CLARA, Calif., May 29, 2024 /PRNewswire/...
Gary Cohen, Former Gillette, Timex and Energizer Executive, Named as Company's New CEO Company Updates Outlook for Full Year 2024...
Canoo Inc. LogoJustin, TX, May 03, 2024 (GLOBE NEWSWIRE) -- Canoo Inc. (Nasdaq: GOEV), a high-tech advanced mobility company, today...
Quantum eMotion (QeM) Announce Financial and Operating Results for the Year Ending December 31, 2023
Montreal, Quebec--(Newsfile Corp. - May 1, 2024) - Quantum eMotion Corp. (TSXV: QNC) (OTCQB: QNCCF) is pleased to share its...
Ascendis PharmaCOPENHAGEN, Denmark, April 25, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report first...
